Cannabis use and the mental health of young people

References

• Hall W D, Pacula R L. Cannabis use and dependence: public health and public policy. Cambridge University Press, Cambridge 2003
   Google Scholar
• Fergusson D M, Horword L J, Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002; 97: 1123–1135
   PubMed Web of Science ®Google Scholar
• Lynskey M, Hall W D. The effects of adolescent cannabis use on educational attainment: a review. Addiction 2000; 96: 433–443
   Google Scholar
• MacLeod J, Oakes R, Copello A, et al. The psychosocial consequences of use of cannabis and other illicit drugs: systematic review of longitudinal, general population studies. Lancet 2004; 363: 1579–1588
   PubMed Web of Science ®Google Scholar
• Adams I B, Martin B R. Cannabis: pharmacology and toxicology in animals and humans. Addiction 1996; 91: 1585–1614
   PubMed Web of Science ®Google Scholar
• Compton D R, Dewey W L, Martin B R. Cannabis dependence and tolerance production. Advances in Alcohol and Substance Abuse 1990; 9: 129–147
   PubMedGoogle Scholar
• Maldonado R. Study of cannabinoid dependence in animals. Pharmacology and Therapeutics 2002; 95: 153–164
   PubMed Web of Science ®Google Scholar
• Aceto M, Scates S, lowe A, Martin B. Dependence studies on delta-9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. Journal of Pharmacology and Experimental Therapeutics 1996; 278: 1290–1295
   PubMed Web of Science ®Google Scholar
• Cook S A, Lowe J A, Martin B R. CB1 receptor antagonist precipitates withdrawal in mice exposed to delta9-tetrahydrocannabinol. Journal of Pharmacology and Experimental Therapeutics 1998; 285: 1150–1156
   PubMedGoogle Scholar
• Copeland J, Swift W, Rees V. Clinical profile of participants in a brief intervention program for cannabis use disorder. Journal of Substance Abuse Treatment 2001; 20: 45–52
   PubMed Web of Science ®Google Scholar
• Stephens R S, Roffman R A, Simpson E E. Treating adult marijuana dependence –a test of the relapse prevention model. Journal of Consulting and Clinical Psychology 1994; 62: 92–99
   PubMed Web of Science ®Google Scholar
• Swift W, Hall W D, Copeland J. Characteristics of long-term cannabis users in Sydney, Australia. European Addiction Research 1998; 4: 190–197
   PubMedGoogle Scholar
• Wiesbeck G A, Schuckit M A, Kalmijn J A, Tipp J E, Bucholz K K, Smith T L. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction 1996; 91: 1469–1478
   PubMed Web of Science ®Google Scholar
• Robins L N, Reiger D A. Psychiatric disorders in America: the epidemiological catchment area study, L N Robins, D A Reiger. Free Press, New York 1991
   Google Scholar
• Anthony J C, Warner L, Kessler R. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology 1994; 2: 244–268
   Web of Science ®Google Scholar
• Hwu H G, Compton W M. Comparison of major epidemiological surveys using the Diagnostic Interview Schedule. International Review of Psychiatry 1994; 6: 309–327
   Google Scholar
• Russell J M, Newman S C, Bland R C. Drug abuse and dependence. Acta Psychiatrica Scandinavica 1994; 89: 54–62
   Google Scholar
• Wells J, Bushnell J, Joyce P R, Oakley-Browne M, Hornblow A. Problems with alcohol, drugs and gambling in Christchurch, New Zealand. Alcohol and drug dependence and disorders of impulse control, M Abbot, K Evans. Alcohol Liquor Advisory Council, Auckland 1992; 3–13
   Google Scholar
• Hall W D, Teesson M, Lynskey M, Degenhardt L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-being. Addiction 1999; 94: 1541–1550
   PubMed Web of Science ®Google Scholar
• Hall W D, Solowij N, Lemon J. The health and psychological consequences of cannabis use. Australian Government Publishing Service, Canberra 1994
   Google Scholar
• Brook J S, Cohen P, Whiteman M, Gordon A S. Psychosocial risk factors in the transition from moderate to heavy use or abuse of drugs. Vulnerability to drug abuse, M D Glantz. American Psychological Association, Washington, DC 1992; 359–388
   Google Scholar
• Kandel D B, Davies M. Progression to regular marijuana involvement: phenomenology and risk factors for near-daily use. Vulnerability to drug abuse, M D Glantz. American Psychological Association, Washington, DC 1992; 211–253
   Google Scholar
• Newcomb M D. Understanding the multidimensional nature of drug use and abuse: the role of consumption, risk factors, and protective factors. Vulnerability to drug abuse, M D Glantz. American Psychological Association, Washington, DC 1992; 255–297
   Google Scholar
• Shedler J, Block J. Adolescent drug use and psychological health: a longitudinal inquiry. American Psychologist 1990; 45: 612–630
   PubMed Web of Science ®Google Scholar
• Budney A J, Moore B A. Development and consequences of cannabis dependence. Journal of Clinical Pharmacology 2002; 42: 28S–33S
   PubMed Web of Science ®Google Scholar
• Stephens R S, Babor T F, Kadden R, Miller M. The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction 2002; 97: 109–124
   PubMed Web of Science ®Google Scholar
• Crowley T J, Macdonald M J, Whitmore E A, Mikulich S K. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug and Alcohol Dependence 1998; 50: 27–37
   PubMed Web of Science ®Google Scholar
• Tims F M, Dennis M L, Hamilton N, et al. Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment. Addiction 2002; 97: 46–57
   PubMed Web of Science ®Google Scholar
• Morral A R, McCaffrey D F, Paddock S M. Reassessing the marijuana gateway effect. Addiction 2002; 97: 1493–1504
   PubMed Web of Science ®Google Scholar
• Kandel D B. Stages in adolescent involvement in drug use. Science 1975; 190: 912–914
   PubMed Web of Science ®Google Scholar
• Kandel D B. Stages and pathways of drug involvement: examining the gateway hypothesis, D B Kandel. Cambridge University Press, New York 2002
   Google Scholar
• Kandel D B. Marijuana users in young adulthood. Archives of General Psychiatry 1984; 41: 200–209
   PubMed Web of Science ®Google Scholar
• Donnelly N, Hall W D. Patterns of cannabis use in Australia. Australian Government Publishing Service, Canberra 1994
   Google Scholar
• Donovan J E, Jessor R. Problem drinking and the dimension of involvement with drugs: a Guttman scalogram analysis of adolescent drug use. American Journal of Public Health 1983; 73: 543–552
   PubMed Web of Science ®Google Scholar
• Kandel D B. Issues of sequencing of adolescent drug use and other problem behaviors. Drugs and Society 1988; 3: 55–76
   Google Scholar
• Cohen S. Drug use: religion and secularization. American Journal of Psychiatry 1972; 129: 97
   PubMedGoogle Scholar
• Goode E. Marijuana use and the progression to dangerous drugs. Marijuana: effects on human behavior, L L Miller. Academic Press, New York 1974; 303–338
   Google Scholar
• Wagner F A, Anthony J C. Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. American Journal of Epidemiology 2002; 155: 918–925
   PubMed Web of Science ®Google Scholar
• Fergusson D M, Horwood L J. Does cannabis use encourage other forms of illicit drug use?. Addiction 2000; 95: 505–520
   PubMed Web of Science ®Google Scholar
• Kaplan H B, Martin S S, Robbins C. Pathways to adolescent drug use: self-derogation, peer influence, weakening of social controls, and early substance use. Journal of Health and Social Behavior 1984; 25: 270–289
   PubMed Web of Science ®Google Scholar
• Newcomb M D, Bentler P M. Consequences of adolescent drug use: impact on the lives of young adults. Sage, Thousand Oaks, CA 1988
   Google Scholar
• Jessor R, Jessor S L. Problem behavior and psychosocial development: a longitudinal study of youth. Academic Press, New York 1977
   Google Scholar
• Osgood D W, Johnston L D, O'Malley P M, Bachman J G. The generality of deviance in late adolescence and early adulthood. American Sociological Review 1988; 53: 81–93
   Web of Science ®Google Scholar
• McGee R, Feehan M. Cannabis use among New Zealand adolescents. New Zealand Medical Journal 1993; 106: 345
   PubMedGoogle Scholar
• Jessor R, Jessor S L. Theory testing in longitudinal research on marijuana use. Longitudinal research on drug use: empirical findings and methodological issues, D B Kandel. Wiley, New York 1978; 41–71
   Google Scholar
• Bailey S L, Flewelling R L, Rachal J V. Predicting continued use of marijuana among adolescents: the relative influence of drug-specific and social context factors. Journal of Health and Social Behavior 1992; 33: 51–66
   PubMed Web of Science ®Google Scholar
• Hawkins J D, Catalano R F, Miller J Y. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychological Bulletin 1992; 112: 64–105
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Kandel D B. Patterns of drug use from adolescence to young adulthood: III. Predictors of progression. American Journal of Public Health 1984; 74: 673–681
   PubMed Web of Science ®Google Scholar
• True W R, Heath A C, Scherrer J F, et al. Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms. American Journal of Medical Genetics 1999; 88: 391–397
   PubMed Web of Science ®Google Scholar
• Lynskey M T, Heath A C, Bucholz K K, Slutske W S. Escalation of drug use in early-onset cannabis users vs co-twin controls. Journal of the American Medical Association 2003; 289: 427–433
   PubMed Web of Science ®Google Scholar
• Nahas G G. Keep off the grass5th edn. Paul Eriksson, Middlebury, VT 1990
   Google Scholar
• Gardner E L. Cannabinoid interaction with brain reward systems. Marihuana and medicine, G Nahas, K M Sutin, D Harvey, S Agurell. Humana Press, Towa, NJ 1999; 187–205
   Google Scholar
• Manzanares J, Corchero J, Romero J, Fernandez-Ruiz J J, Ramos J A, Fuentes J A. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends in Pharmacological Sciences 1999; 20: 287–294
   PubMed Web of Science ®Google Scholar
• Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G. Behavioural sensitization after repeated exposure to [Delta]9-tetrahydrocannabinol cross-sensitization with morphine. Psychopharmacology 2001; 158: 259–266
   PubMed Web of Science ®Google Scholar
• Lamarque S, Taghzouti K, Simon H. Chronic treatment with [Delta] 9-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin: implications for vulnerability to drug addiction. Neuropharmacology 2001; 41: 118–129
   PubMedGoogle Scholar
• Lynskey M. An alternative model is feasible, but the gateway hypothesis has not been invalidated: comments on Morral et al. Addiction 2002; 97: 1505–1507
   PubMedGoogle Scholar
• Polich J M, Ellickson P L, Reuter P, Kahan J P. Strategies for controlling adolescent drug use. RAND, Santa Monica, CA 1984
   Google Scholar
• Botvin G J, Scheier L M, Griffin K W. Preventing the onset and developmental progression of adolescent drug use: implications for the gateway hypothesis. Stages and pathways of drug involvement: examining the gateway hypothesis, D B Kandel. Cambridge University Press, New York 2002; 115–138
   Google Scholar
• Caulkins J P, Rydell C P, Everingham S MS, Chiesa J R, Bushway S. An ounce of prevention, a pound of uncertainty: the cost-effectiveness of school-based drug prevention programs. RAND, Santa Monica, CA 1999
   Google Scholar
• Baumrind D, Moselle K A. A developmental perspective on adolescent drug abuse. Advances in Alcohol and Substance Abuse 1985; 4: 41–67
   PubMedGoogle Scholar
• Kandel D B, Davies M, Karus D, Yamaguchi K. The consequences in young adulthood of adolescent drug involvement: an overview. Archives of General Psychiatry 1986; 43: 746–754
   PubMed Web of Science ®Google Scholar
• Duncan S C, Duncan T E, Biglan A, Ary D. Contributions of the social context to the development of adolescent substance use: a multivariate latent growth modeling approach. Drug and Alcohol Dependence 1998; 50: 57–71
   PubMed Web of Science ®Google Scholar
• Hundleby J D, Mercer G W. Family and friends as social environments and their relationship to young adolescents’ use of alcohol, tobacco, and marijuana. Journal of Marriage and the Family 1987; 49: 151–164
   Web of Science ®Google Scholar
• Jessor R. Predicting time of onset of marijuana use: a developmental study of high school youth. Journal of Consulting and Clinical Psychology 1976; 44: 125–134
   PubMed Web of Science ®Google Scholar
• Kelly D, Balch R W. Social origins and school failure: a re-examination of Cohen's theory of working-class delinquency. Pacific Sociological Review 1971; 14: 413–430
   Google Scholar
• Krohn M D, Lizotte A J, Perez C M. The interrelationship between substance use and precocious transitions to adult statuses. Journal of Health and Social Behavior 1997; 38: 87–103
   PubMed Web of Science ®Google Scholar
• Kandel D B. Drug and drinking behavior among youth. Annual Review of Sociology 1980; 6: 235–285
   Web of Science ®Google Scholar
• Newcomb M D, Bentler P M. Substance use and abuse among children and teenagers. American Psychologist 1989; 44: 242–248
   PubMed Web of Science ®Google Scholar
• Rutter M. Longitudinal data in the study of causal processes: some uses and some pitfalls. Studies of psychosocial risk: the power of longitudinal data, M Rutter. Cambridge University Press, Cambridge, UK 1988; 12–19
   Google Scholar
• Fergusson D M, Lynskey M T, Horwood L J. The short-term consequences of early onset cannabis use. Journal of Abnormal Child Psychology 1996; 24: 499–512
   PubMed Web of Science ®Google Scholar
• Ellickson P, Bui K, Bell R, McGuigan K A. Does early drug use increase the risk of dropping out of high school?. Journal of Drug Issues 1998; 28: 357–380
   Web of Science ®Google Scholar
• Tanner J, Davies S, O'Grady B. Whatever happened to yesterday's rebels? Longitudinal effects of youth delinquency on education and employment. Social Problems 1999; 46: 250–274
   Web of Science ®Google Scholar
• Tien A Y, Anthony J C. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. Journal of Nervous and Mental Disease 1990; 178: 473–480
   PubMed Web of Science ®Google Scholar
• Thomas H. A community survey of adverse effects of cannabis use. Drug and Alcohol Dependence 1996; 42: 201–207
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Hall W D. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-being. Psychological Medicine 2001; 31: 659–668
   PubMed Web of Science ®Google Scholar
• Schneier F R, Siris S G. A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. Journal of Nervous and Mental Disease 1987; 175: 641–652
   PubMed Web of Science ®Google Scholar
• Smith J, Hucker S. Schizophrenia and substance abuse. British Journal of Psychiatry 1994; 165: 13–21
   PubMed Web of Science ®Google Scholar
• Warner R, Taylor D, Wright J, et al. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. American Journal of Orthopsychiatry 1994; 64: 30–39
   PubMed Web of Science ®Google Scholar
• Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biological Psychiatry 1996; 40: 1155–1163
   PubMed Web of Science ®Google Scholar
• Mueser K T, Bellack A S, Blanchard J J. Comorbidity of schizophrenia and substance abuse: implications for treatment. Journal of Consulting and Clinical Psychology 1992; 60: 845–856
   PubMed Web of Science ®Google Scholar
• Hall W D. Cannabis and psychosis. Drug and Alcohol Review 1998; 17: 433–444
   PubMed Web of Science ®Google Scholar
• Thornicroft G. Cannabis and psychosis: is there epidemiological evidence for association?. British Journal of Psychiatry 1990; 157: 25–33
   PubMed Web of Science ®Google Scholar
• Andreasson S, Engstrom A, Allebeck P, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483–1486
   PubMed Web of Science ®Google Scholar
• Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal 2002; 325: 1199–1201
   PubMed Web of Science ®Google Scholar
• van Os J, Bak M, Hanssen M, Bijl R V, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 2002; 156: 319–327
   PubMed Web of Science ®Google Scholar
• Henquet C, Krabbendam L, Spauwen J, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 2005; 330: 11
   PubMed Web of Science ®Google Scholar
• Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt T E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal 2002; 325: 1212–1213
   PubMed Web of Science ®Google Scholar
• Fergusson D M, Horwood J L, Swain-Campbell N R. Cannabis dependence and psychotic symptoms in young people. Psychological Medicine 2003; 33: 15–21
   PubMed Web of Science ®Google Scholar
• Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen J. Cannabis use and the expression of psychosis vulnerability in daily life. European Psychiatry 2002; 17: 180s
   Google Scholar
• McGuire P K, Jones P, Harvey I, Williams M, McGuffin P, Murray R M. Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophrenia Research 1995; 15: 277–281
   PubMed Web of Science ®Google Scholar
• D'souza D C, Cho H S, Perry E B, Krystal J H. Cannabinoid ‘model’ psychosis, dopamine-cannabinoid interactions and implications for schizophrenia. Marijuana and madness: psychiatry and neurobiology, D Castle, R Murray. Cambridge University Press, Cambridge 2004; 142–165
   Google Scholar
• Caspi A, Moffitt T E, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene × environment interaction. Biological Psychiatry 2005; 57: 1117–1127
   PubMed Web of Science ®Google Scholar
• Hall W, Swift W. The THC content of cannabis in Australia: evidence and implications. Australian and New Zealand Journal of Public Health 2000; 24: 503–508
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. An overview of cannabis potency in Europe. EMCDDA, Lisbon 2004
   Google Scholar
• ElSohly M A, Ross S A. Quarterly report: potency monitoring project. Report 69: January 1, 1999–March 31, 1999. National Center for the Development of Natural Products, University of Mississippi, Oxford, MS 1999
   Google Scholar
• ElSohly M A, Ross S A, Mehmedic Z, Arafat R, Yi B, Banahan B F. Potency trends of delta(9)-THC and other cannabinoids in confiscated marijuana from 1980–1997. Journal of Forensic Sciences 2000; 45: 24–30
   PubMed Web of Science ®Google Scholar
• Hall W D, Lynskey M. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug and Alcohol Review 2005; 24: 39–48
   PubMed Web of Science ®Google Scholar
• Hall W D, Degenhardt L, Teesson M. Cannabis use and psychotic disorders: an update. Drug and Alcohol Review 2004; 23: 433–443
   PubMed Web of Science ®Google Scholar